Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proton pump inhibitor use may not prevent high-grade dysplasia and oesophageal adenocarcinoma in Barrett's oesophagus: a nationwide study of 9883 patients.
Hvid-Jensen F, Pedersen L, Funch-Jensen P, Drewes AM. Hvid-Jensen F, et al. Aliment Pharmacol Ther. 2014 May;39(9):984-91. doi: 10.1111/apt.12693. Epub 2014 Mar 11. Aliment Pharmacol Ther. 2014. PMID: 24617286 Free article.
Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus--authors' reply.
Hvid-Jensen F, Drewes AM, Funch-Jensen P. Hvid-Jensen F, et al. Aliment Pharmacol Ther. 2014 Oct;40(7):860-1. doi: 10.1111/apt.12931. Aliment Pharmacol Ther. 2014. PMID: 25185739 Free article. No abstract available.
Letter: proton pump inhibitors, GERD and oesophageal adenocarcinoma - authors' reply.
Hvid-Jensen F, Funch-Jensen P, Drewes AM. Hvid-Jensen F, et al. Aliment Pharmacol Ther. 2014 Aug;40(3):320. doi: 10.1111/apt.12847. Aliment Pharmacol Ther. 2014. PMID: 25040747 Free article. No abstract available.
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain.
Krarup AL, Ny L, Astrand M, Bajor A, Hvid-Jensen F, Hansen MB, Simrén M, Funch-Jensen P, Drewes AM. Krarup AL, et al. Aliment Pharmacol Ther. 2011 May;33(10):1113-22. doi: 10.1111/j.1365-2036.2011.04629.x. Epub 2011 Mar 16. Aliment Pharmacol Ther. 2011. PMID: 21410733 Clinical Trial.
Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting.
Hvid-Jensen F, Nielsen RB, Pedersen L, Funch-Jensen P, Drewes AM, Larsen FB, Thomsen RW. Hvid-Jensen F, et al. Clin Epidemiol. 2013 Dec 4;5:493-9. doi: 10.2147/CLEP.S49354. eCollection 2013. Clin Epidemiol. 2013. PMID: 24348070 Free PMC article.
Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain.
Krarup AL, Ny L, Gunnarsson J, Hvid-Jensen F, Zetterstrand S, Simrén M, Funch-Jensen P, Hansen MB, Drewes AM. Krarup AL, et al. Among authors: hvid jensen f. Scand J Gastroenterol. 2013 Mar;48(3):274-84. doi: 10.3109/00365521.2012.758769. Epub 2013 Jan 16. Scand J Gastroenterol. 2013. PMID: 23320520 Clinical Trial.
Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Hvid-Jensen F, et al. N Engl J Med. 2011 Oct 13;365(15):1375-83. doi: 10.1056/NEJMoa1103042. N Engl J Med. 2011. PMID: 21995385 Free article.
Long-term complications to reflux disease in community practice. A 17-year cohort study of 4706 patients.
Hvid-Jensen F, Pedersen L, Munk EM, Drewes AM, Funch-Jensen P. Hvid-Jensen F, et al. Scand J Gastroenterol. 2011 Oct;46(10):1179-86. doi: 10.3109/00365521.2011.594084. Epub 2011 Jul 27. Scand J Gastroenterol. 2011. PMID: 21793632
Barrett's oesophagus: size does matter.
de Jonge PJ, Hvid-Jensen F. de Jonge PJ, et al. Among authors: hvid jensen f. Gut. 2016 Feb;65(2):189-90. doi: 10.1136/gutjnl-2015-310091. Epub 2015 Aug 5. Gut. 2016. PMID: 26246246 No abstract available.
Should aspirin and PPIs be recommended for patients with Barrett's oesophagus?
Hvid-Jensen F, Drewes AM. Hvid-Jensen F, et al. Lancet. 2018 Aug 4;392(10145):362-364. doi: 10.1016/S0140-6736(18)31618-0. Epub 2018 Jul 26. Lancet. 2018. PMID: 30057101 Free article. No abstract available.
12 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback